KUALA LUMPUR: Mah Sing Group Bhd
has received 99.996 per cent shareholders’ approval for its proposed diversification into glove manufacturing and trading, and related healthcare products via Mah Sing Healthcare Sdn Bhd.
It said the first six production lines at Mah Sing’s first glove manufacturing factory in Kapar, Klang would be operational as planned in the second quarter of 2021, followed by another six lines expected to be ready in the third quarter, with a total maximum capacity of up to 3.68 billion pieces of gloves per annum.
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
